IPDC_RHOJR
ID IPDC_RHOJR Reviewed; 353 AA.
AC Q0S7Q1;
DT 07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT 05-SEP-2006, sequence version 1.
DT 03-AUG-2022, entry version 103.
DE RecName: Full=(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1-oxo-octahydro-1H-indene-4-carboxyl-CoA dehydrogenase {ECO:0000305};
DE Short=5OH-HIC-CoA dehydrogenase {ECO:0000305};
DE EC=1.3.1.- {ECO:0000250|UniProtKB:P71847};
GN Name=ipdC {ECO:0000303|PubMed:28377529};
GN OrderedLocusNames=RHA1_ro04649 {ECO:0000312|EMBL:ABG96435.1};
OS Rhodococcus jostii (strain RHA1).
OC Bacteria; Actinobacteria; Corynebacteriales; Nocardiaceae; Rhodococcus.
OX NCBI_TaxID=101510;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=RHA1;
RX PubMed=17030794; DOI=10.1073/pnas.0607048103;
RA McLeod M.P., Warren R.L., Hsiao W.W.L., Araki N., Myhre M., Fernandes C.,
RA Miyazawa D., Wong W., Lillquist A.L., Wang D., Dosanjh M., Hara H.,
RA Petrescu A., Morin R.D., Yang G., Stott J.M., Schein J.E., Shin H.,
RA Smailus D., Siddiqui A.S., Marra M.A., Jones S.J.M., Holt R.,
RA Brinkman F.S.L., Miyauchi K., Fukuda M., Davies J.E., Mohn W.W.,
RA Eltis L.D.;
RT "The complete genome of Rhodococcus sp. RHA1 provides insights into a
RT catabolic powerhouse.";
RL Proc. Natl. Acad. Sci. U.S.A. 103:15582-15587(2006).
RN [2]
RP FUNCTION, PATHWAY, AND DISRUPTION PHENOTYPE.
RC STRAIN=RHA1;
RX PubMed=28377529; DOI=10.1128/mbio.00321-17;
RA Crowe A.M., Casabon I., Brown K.L., Liu J., Lian J., Rogalski J.C.,
RA Hurst T.E., Snieckus V., Foster L.J., Eltis L.D.;
RT "Catabolism of the last two steroid rings in Mycobacterium tuberculosis and
RT other bacteria.";
RL MBio 8:e00321-e00321(2017).
CC -!- FUNCTION: Involved in the final steps of cholesterol and steroid
CC degradation (PubMed:28377529). Probably catalyzes the introduction of a
CC double bound into the C ring of 5OH-HIC-CoA, leading to the formation
CC of (5R,7aS)-5-hydroxy-7a-methyl-1-oxo-3,5,6,7-tetrahydro-2H-indene-4-
CC carboxyl-CoA (By similarity). {ECO:0000250|UniProtKB:P71847,
CC ECO:0000269|PubMed:28377529}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1-oxo-octahydro-1H-indene-
CC 4-carboxyl-CoA + NAD(+) = (5R,7aS)-5-hydroxy-7a-methyl-1-oxo-
CC 2,3,5,6,7,7a-hexahydro-1H-indene-carboxyl-CoA + H(+) + NADH;
CC Xref=Rhea:RHEA:66352, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC ChEBI:CHEBI:57945, ChEBI:CHEBI:167058, ChEBI:CHEBI:167096;
CC Evidence={ECO:0000250|UniProtKB:P71847};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66353;
CC Evidence={ECO:0000250|UniProtKB:P71847};
CC -!- PATHWAY: Steroid metabolism; cholesterol degradation.
CC {ECO:0000269|PubMed:28377529}.
CC -!- DISRUPTION PHENOTYPE: Deletion mutant does not grow on cholesterol or
CC HIP, but grows as the wild-type on pyruvate. In the presence of
CC cholesterol, disruption mutant accumulates 5OH-HIC-CoA.
CC {ECO:0000269|PubMed:28377529}.
CC -!- SIMILARITY: Belongs to the nitronate monooxygenase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000431; ABG96435.1; -; Genomic_DNA.
DR RefSeq; WP_011597003.1; NC_008268.1.
DR AlphaFoldDB; Q0S7Q1; -.
DR SMR; Q0S7Q1; -.
DR STRING; 101510.RHA1_ro04649; -.
DR EnsemblBacteria; ABG96435; ABG96435; RHA1_ro04649.
DR KEGG; rha:RHA1_ro04649; -.
DR PATRIC; fig|101510.16.peg.4692; -.
DR eggNOG; COG2070; Bacteria.
DR HOGENOM; CLU_038732_1_1_11; -.
DR OMA; IDDLPSC; -.
DR UniPathway; UPA01058; -.
DR Proteomes; UP000008710; Chromosome.
DR GO; GO:0018580; F:nitronate monooxygenase activity; IEA:InterPro.
DR GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR GO; GO:0006707; P:cholesterol catabolic process; IEA:UniProtKB-UniPathway.
DR CDD; cd04730; NPD_like; 1.
DR Gene3D; 3.20.20.70; -; 1.
DR InterPro; IPR013785; Aldolase_TIM.
DR InterPro; IPR004136; NMO.
DR Pfam; PF03060; NMO; 2.
PE 3: Inferred from homology;
KW Cholesterol metabolism; Flavoprotein; FMN; Lipid metabolism; NAD;
KW Nucleotide-binding; Oxidoreductase; Reference proteome; Steroid metabolism;
KW Sterol metabolism.
FT CHAIN 1..353
FT /note="(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1-oxo-octahydro-
FT 1H-indene-4-carboxyl-CoA dehydrogenase"
FT /id="PRO_0000452308"
FT BINDING 22..24
FT /ligand="FMN"
FT /ligand_id="ChEBI:CHEBI:58210"
FT /evidence="ECO:0000250|UniProtKB:Q9I4V0"
FT BINDING 171..173
FT /ligand="FMN"
FT /ligand_id="ChEBI:CHEBI:58210"
FT /evidence="ECO:0000250|UniProtKB:Q9I4V0"
FT BINDING 194..195
FT /ligand="FMN"
FT /ligand_id="ChEBI:CHEBI:58210"
FT /evidence="ECO:0000250|UniProtKB:Q9I4V0"
SQ SEQUENCE 353 AA; 36550 MW; 2AF75DACC9596EB7 CRC64;
MSTLRTALTE LVGVQHPVVQ TGMGWVAGPR LVAGTANAGG LGILASATMT YTELESAITK
TKTLTDKPFG VNIRADASDA PHRIDLLIRE SVRVASFALA PKQELIAKLK AAGVVVIPSI
GAAKHAKKVA SWGADAVIVQ GGEGGGHTGP VATTLLLPSV LDAVDIPVVA AGGFYDGRGL
AAALAYGAAG VAMGTRFLLT QESTVPDSVK HEYLARGLQD TTVSRKVDGM PHRVLNTDLV
NSLEHSGNMR GLVAAARNAS KFKAMTGMKW STLVKDGLAM KKSSDRTWQQ IIMAANTPML
LKAGLVEGNT HAGVLASGQV VGLLDDLPTC KDLIDGIVAD AIKRIDALGA LRA